Sort
51,593 grants matching “hepatitis”
Clinical Studies of Inflammatory Bowel Diseases
$398,172Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Hexokinase 2 in liver cancer
$398,154Nissim Hay · University Of Illinois At Chicago · R01 · FY2016 · CA
Role of the RB tumor suppressor in liver tumorigenesis
$398,137Erik Knudsen · Ut Southwestern Medical Center · R01 · FY2015 · CA
ADOLESCENTS IN THE DRUG CULTURE AND STD TRANSMISSION
$398,102Emory University · U01 · FY2000 · AI
Hydroxyurea Pharmacokinetics and Pharmacogenomics
$398,080Russell E Ware · Baylor College Of Medicine · R01 · FY2011 · HL
Partnership for developing broad-spectrum microbicides
$398,049Thomas Michael Zydowsky · Population Council · U01 · FY2009 · AI
Development of first-in-class antagonists of the retinoid pathway as novel oral immunotherapies for solid cancers
$398,040Mark Esposito · Kayothera Inc. · R43 · FY2023 · CA
Cytokine-stimulated systemic defenses during pneumococcal pneumonia
$398,027Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2014 · HL
Novel noncanonical actions of CAR in human Liver
$398,021Hongbing Wang · University Of Maryland Baltimore · R01 · FY2025 · CA
Bariatric Surgery Research Consortium
$398,005University Of Washington · U01 · FY2004 · DK
Herb-Opioid Interactions
$397,999Fred Hutchinson Cancer Research Center · R01 · FY2001 · AT
Nutritional Treatment of Fat Oxidation Defect in Mice
$397,978Henri Brunengraber · Case Western Reserve University · R01 · FY2007 · DK
Inhaled inhibitors of TGFB activation by integrins
$397,977Dean Sheppard · University Of California, San Francisco · P01 · FY2015 · HL
Quantitative characterization of the liver-pancreas axis in diabetes via multiparametric magnetic resonance elastography
$397,974Meng Yin · Mayo Clinic Rochester · R01 · FY2023 · DK
Mechanisms of antibody-mediated control of repeated hepatitis C virus infection in humans
$397,972Justin Richard Bailey · Johns Hopkins University · U19 · FY2025 · AI
Clinical Studies of Inflammatory Bowel Diseases
$397,961Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
PRECLINICAL EVAL. OF THERAPIES FOR MICROSPORIDIAL INFECT
$397,907Tulane University Of Louisiana · N01 · FY2000 · AI
Development of a charge detection mass spectrometer for the analysis ofgene therapy and other large pharmaceutical biologics
$397,898Benjamin E Draper · Megadalton Solutions, Inc · R44 · FY2021 · GM
High-Tc susceptometer to monitor transfusional iron overload (NSR device)
$397,880Gary M Brittenham · Columbia University Health Sciences · R01 · FY2014 · FD
Evaluation of a Hepatitis B Outreach Intervention for Cambodians
$397,878Victoria M Taylor · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
Development of cell-free DNA assays for HCC screening and liquid biopsy
$397,877Ying-Hsiu Su · Baruch S. Blumberg Institute · R01 · FY2020 · CA
Development of cell-free DNA assays for HCC screening and liquid biopsy
$397,877Ying-Hsiu Su · Baruch S. Blumberg Institute · R01 · FY2018 · CA
ROLE OF ENZYME INDUCTION IN CANCER CHEMOPREVENTION
$397,876Thomas W Kensler · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · CA
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
$397,811W Mark Saltzman · Yale University · R01 · FY2014 · HL
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.
$397,803Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2012 · HD